NEWS

WIRES

OTHER

Feelgoods International to Revolutionize European Pharmacies Through Health Food and Supplement Franchises

Feelgoods International Ltd. (OTC: FGNL) is pleased to announce that CEO Marcel Maurer was recently interviewed on Macreport.net. In his interview, Mr. Maurer highlighted the Company's strategy to significantly increase individual European pharmacy revenues through the rollout of their Health Foods and Supplements Franchises.

Feelgoods International's plan of action is to introduce the rapidly growing health foods and supplements industry into the existing European pharmacy structure, and as a result, effectively increase income and profitability. By incorporating a segment which is gaining popularity in the European Marketplace, it allows pharmacies which already have an established client base to maximize the spending potential of their current clients, as well as attract a new target market. Hence, this will enable Feelgoods International to sell more franchises throughout Europe.

"Pharmacies in Europe are very different from the pharmacies in the United States. They are much smaller, only 1000 to 3000 square feet, and they focus primarily on the treatment of illnesses and not the prevention of them. This franchise concept will bring traditional European Pharmacies into the 21st Century," stated Marcel Maurer, CEO of Feelgoods International Ltd.

To listen to the presentation in its entirety go to: http://www.macreport.net/

About Feelgoods International Ltd.

Based in Zurich-Kloten, Switzerland, Feelgoods International Ltd. offers a unique franchise business opportunity for thousands of European Pharmacies. The franchise system is designed to significantly increase the pharmacy's revenue by maximizing the revenue potential of a Pharmacy's existing customer traffic. The Feelgoods' model is easily incorporated into a Pharmacy's existing floor space, producing a self-contained business or 'shop within a shop.' Feelgoods' focus is on products that complement the pharmacy's conventional inventory by introducing products such as alternative medications, nutriceuticals, lifestyle products and bio cosmetics.

For more information, please visit:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Distributed by Market Wire